Clinical Trial Update: Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A phase 2 clinical trial assessing the combination of irinotecan, carboplatin, bevacizumab, and radiation therapy for limited-stage small cell lung cancer has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Camptosar (irinotecan)
• Paraplatin (Carboplatin)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Carcinoma, Small Cell Lung, Lung Cancer | Phase 2 | Status: COMPLETED